Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2019-08-24 2019-08-23
Drug Identification Number 02461692 02461692
Brand name CUVITRU CUVITRU
Common or Proper name Immune globulin Subcutaneous 20% Immune globulin Subcutaneous 20%
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients IMMUNOGLOBULIN IMMUNOGLOBULIN
Strength(s) 200MG 200MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1g, 2g,4g and 8g 1g, 2g,4g and 8g
ATC code J06BA J06BA
ATC description IMMUNOGLOBULINS IMMUNOGLOBULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-04-09 2019-04-09
Actual start date 2019-05-09 2019-05-09
Estimated end date 2019-09-30 2019-09-30
Actual end date 2019-08-23 2019-08-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage resolved on 2019-08-23 Shortage resolved on 2019-08-23
Health Canada comments